Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries

Carlos Chiattonea Hematology and Oncology Discipline, Santa Casa Medical School, Sao Paulo, BrazilView further author information

David Gomez-Almaguerb Hematology Service, Hospital Universitario “Dr. José E. González”, Monterrey, Mexico

Carolina Pavlovskyc FUNDALEU Hospital and Clinical Research Centre, Buenos Aires, ArgentinaView further author information

Elena J. Tuna-Aguilard Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoView further author information

Ana L. Basquierae Hematology, Hospital Privado Centro Medico de Cordoba, Cordoba, ArgentinaView further author information

Luis Palmerf Complejo Medico de la PFA Churruca – Visca, ArgentinaView further author information

Danielle Leao Cordeiro de Fariasg Hospital das Clinicas da Universidade Federal de Goias, Goiânia, Brazil

Sergio Schusterschitz da Silva Araujoh Hospital das Clínicas - Universidade Federal de Minas Gerais, BrazilView further author information

Jennifer H. Link Janssen Scientific Affairs, LLC, Titusville, NJ, USAView further author information

Yen-wen Chenk Janssen Scientific Affairs, LLC, Titusville, NJ, USAView further author information

Gerardo Machnickil Janssen Cilag Farmaceutica SA, Buenos Aires, ArgentinaView further author information

Michelle Mahlerm Janssen Global Services, LLC, Raritan, NJ, USAView further author information

Lori Parisin Janssen Pharmaceutical Companies of Johnson and Johnson, Titusville, NJ, USAView further author information

Paula Barreyrol Janssen Cilag Farmaceutica SA, Buenos Aires, ArgentinaCorrespondence[email protected]
View further author information

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.